The Texas A&M University Institutional Biosafety Committee (IBC) must approve, prior to initiation, research that involves any of the agents/materials listed below.
Pathogens and potential pathogens of humans, animals, or plants;
Materials potentially containing human pathogens (including human blood, tissue, and cell lines; non-human primate blood, tissue, and cell lines);
Recombinant DNA (and RNA), including creation or use of transgenic plants and animals;
Select agents and toxins (selectagents.gov) including strains and amounts exempted from the select agent regulations;
Any material requiring a CDC import license or a USDA permit.
The IBC reports to the University’s Institutional Official (Vice President for Research) and serves Texas A&M researchers, staff, and educators, as well as additional researchers, staff, and educators from The Texas A&M University System members based on signed Memorandums of Understanding (MOUs). The Biosafety Program supports the IBC. For any questions about IBC services for your research or teaching, contact your research administrator.
Inspections for the IBC are conducted by the biological safety officers in the Biosafety Program. The Biosafety Program provides additional information and resources to help investigators with research involving biohazards:
More information available at https://vpr.tamu.edu/compliance/rcc/ibc.